Literature DB >> 3217542

Radical radiotherapy alone in non-operable breast cancer: the major impact of tumor size and histological grade on prognosis.

F Thomas1, R Arriagada, H Mouriesse, I Sillet-Bach, I Kunkler, F Fontaine, T Le Chevalier, G Contesso, D Sarrazin.   

Abstract

This retrospective study involved 319 non-operable breast cancer patients treated by radiotherapy alone with doses of 65 Gy at the Institut Gustave-Roussy (IGR). These patients either had operable tumors but were unfit for general anesthesia or had inoperable tumors due to local contraindications. Most of them had advanced tumors: 21% less than 7 cm; 30% N2 or N3; 30% with inflammatory carcinomas. The 5- and 10-year survival was 40 and 19%, respectively. The local and distant relapse-free rate was 56 and 33% at 5 years and 44 and 28% at 10 years respectively. Results were analyzed according to tumor size, clinical node involvement, histologic grade, age, skin invasion and tumor dose. A multivariate analysis demonstrated that tumor size (p = 10(-3)) and histological grade (HG) (p = 10(-2)) were both significant factors predicting local relapse. Histological grade (p = 10(-3)), tumor size (p = 10(-2)) and clinical node involvement (p = 10(-2)) were the most significant factors predicting distant relapses. An individual risk (IR) of local recurrence and of distant recurrence was defined according to the above factors and was demonstrated to be good prognostic index. Tumor doses above 80 Gy did not increase local control. We recommend the general use of histological grading as it seems important for prediction of local and distant control in patients treated by radiotherapy alone.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3217542     DOI: 10.1016/0167-8140(88)90222-8

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  7 in total

Review 1.  Predicting outcomes in radiation oncology--multifactorial decision support systems.

Authors:  Philippe Lambin; Ruud G P M van Stiphout; Maud H W Starmans; Emmanuel Rios-Velazquez; Georgi Nalbantov; Hugo J W L Aerts; Erik Roelofs; Wouter van Elmpt; Paul C Boutros; Pierluigi Granone; Vincenzo Valentini; Adrian C Begg; Dirk De Ruysscher; Andre Dekker
Journal:  Nat Rev Clin Oncol       Date:  2012-11-20       Impact factor: 66.675

2.  High fibroblast growth factor 19 (FGF19) expression predicts worse prognosis in invasive ductal carcinoma of breast.

Authors:  Abdelbaset Buhmeida; Ashraf Dallol; Adnan Merdad; Jaudah Al-Maghrabi; Mamdooh A Gari; Muhammad M Abu-Elmagd; Adeel G Chaudhary; Adel M Abuzenadah; Taoufik Nedjadi; Eramah Ermiah; Fatima Al-Thubaity; Mohammed H Al-Qahtani
Journal:  Tumour Biol       Date:  2013-11-19

3.  Redefining radiotherapy for early-stage breast cancer with single dose ablative treatment: a study protocol.

Authors:  R K Charaghvandi; B van Asselen; M E P Philippens; H M Verkooijen; C H van Gils; P J van Diest; R M Pijnappel; M G G Hobbelink; A J Witkamp; T van Dalen; E van der Wall; T C van Heijst; R Koelemij; M van Vulpen; H J G D van den Bongard
Journal:  BMC Cancer       Date:  2017-03-09       Impact factor: 4.430

4.  Decreased expression of C10orf10 and its prognostic significance in human breast cancer.

Authors:  Junjiang Deng; Yan Dong; Chong Li; Wenwei Zuo; Gang Meng; Chengping Xu; Jianjun Li
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240

5.  Definitive hypofractionated radiation therapy for early stage breast cancer: Dosimetric feasibility of stereotactic ablative radiotherapy and proton beam therapy for intact breast tumors.

Authors:  Jonathan W Lischalk; Hao Chen; Michael C Repka; Lloyd D Campbell; Olusola Obayomi-Davies; Shaan Kataria; Thomas P Kole; Sonali Rudra; Brian T Collins
Journal:  Adv Radiat Oncol       Date:  2018-06-11

Review 6.  Altered fractionation in radiation therapy for breast cancer in the elderly: are we moving forward?

Authors:  Valentina Pinzi; Laura Fariselli; Barbara Alicja Jereczek-Fossa
Journal:  Transl Cancer Res       Date:  2020-01       Impact factor: 1.241

Review 7.  Stereotactic radiation therapy for breast cancer in the elderly.

Authors:  Pauline Jardel; Emmanuel Kammerer; Hugo Villeneuve; Juliette Thariat
Journal:  Transl Cancer Res       Date:  2020-01       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.